Copart (CPRT) reported mixed Q2 2026 results, with a decline in global insurance units but an increase in U.S. average selling prices. Despite a 3.6% decrease in consolidated revenue, the company maintains strong financial health, impressive operating margins, and a low debt-to-equity ratio. Valuation metrics suggest the stock is nearing historical lows, potentially indicating an opportunity for investors, though insider selling has been observed.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Copart (CPRT) Reports Mixed Q2 2026 Results Amid Declines in Insurance Units
Copart (CPRT) reported mixed Q2 2026 results, with a decline in global insurance units but an increase in U.S. average selling prices. Despite a 3.6% decrease in consolidated revenue, the company maintains strong financial health, impressive operating margins, and a low debt-to-equity ratio. Valuation metrics suggest the stock is nearing historical lows, potentially indicating an opportunity for investors, though insider selling has been observed.